These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35779665)

  • 21. Rheological characterization and injection forces of concentrated protein formulations: an alternative predictive model for non-Newtonian solutions.
    Allmendinger A; Fischer S; Huwyler J; Mahler HC; Schwarb E; Zarraga IE; Mueller R
    Eur J Pharm Biopharm; 2014 Jul; 87(2):318-28. PubMed ID: 24560966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spray-dried diclofenac-loaded poly(epsilon-caprolactone) nanocapsules and nanospheres. Preparation and physicochemical characterization.
    Müller CR; Schaffazick SR; Pohlmann AR; de Lucca Freitas L; Pesce da Silveira N; Dalla Costa T; Guterres SS
    Pharmazie; 2001 Nov; 56(11):864-7. PubMed ID: 11817171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles.
    Miller MA; Engstrom JD; Ludher BS; Johnston KP
    Langmuir; 2010 Jan; 26(2):1067-74. PubMed ID: 19803503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drying behaviour and visualization of surfactants after co-spray drying of surfactant-stabilized aqueous suspensions.
    De Pauw E; Chen Y; De Keersmaecker H; De Coninck E; De Smet L; De Geest B; Braeckmans K; Vervaet C; Vanhoorne V
    Int J Pharm; 2023 Aug; 643():123231. PubMed ID: 37488060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray drying: Models and pitfalls.
    Batens M; Massant J; Teodorescu B; Van den Mooter G
    Eur J Pharm Biopharm; 2018 Jun; 127():407-422. PubMed ID: 29499299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
    Wanning S; Süverkrüp R; Lamprecht A
    Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T; Li J; Morton DA; Zhou QT; Larson I
    J Pharm Sci; 2016 Mar; 105(3):1156-63. PubMed ID: 26886330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy.
    Li HY; Neill H; Innocent R; Seville P; Williamson I; Birchall JC
    J Drug Target; 2003 Aug; 11(7):425-32. PubMed ID: 15203931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification, characterization and comparative studies of spray-dried bacterial cellulose microparticles.
    Amin MC; Abadi AG; Katas H
    Carbohydr Polym; 2014 Jan; 99():180-9. PubMed ID: 24274495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-spray dried hydrophobic drug formulations with crystalline lactose for inhalation aerosol delivery.
    Ke WR; Kwok PCL; Khanal D; Chang RYK; Chan HK
    Int J Pharm; 2021 Jun; 602():120608. PubMed ID: 33862136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of an oil suspension containing ondansetron hydrochloride as a sustained release parenteral formulation.
    Nguyen TT; Duong VA; Maeng HJ; Chi SC
    Drug Deliv Transl Res; 2020 Feb; 10(1):282-295. PubMed ID: 31659599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration.
    Dani B; Platz R; Tzannis ST
    J Pharm Sci; 2007 Jun; 96(6):1504-17. PubMed ID: 17387698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of oils and pharmaceutical excipients on the bioavailability of ampicillin orally administered, different oily and aqueous suspensions in rabbit.
    Alhamami OM
    Drug Dev Ind Pharm; 2003 Jan; 29(1):51-60. PubMed ID: 12602492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spray pattern and droplet size analyses for high-shear viscosity determination of aqueous suspension corticosteroid nasal sprays.
    Pennington J; Pandey P; Tat H; Willson J; Donovan B
    Drug Dev Ind Pharm; 2008 Sep; 34(9):923-9. PubMed ID: 18800252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism and Impact of Excipient Incompatibility: Cross-Linking of Xanthan Gum in Pediatric Powder-for-Suspension Formulations.
    Li Y; Zhang D; Ash J; Jia X; Leone A; Templeton A
    J Pharm Sci; 2019 Nov; 108(11):3609-3615. PubMed ID: 31348935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of injectable drospirenone organogels with regard to their rheology and comparison to non-stabilized oil-based drospirenone suspensions.
    Nippe S; General S
    Drug Dev Ind Pharm; 2015 Apr; 41(4):681-91. PubMed ID: 24621345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of
    Woldu G; Baymot B; Tesfay D; Demoz GT
    Biomed Res Int; 2021; 2021():5058372. PubMed ID: 34373833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
    Kumar S; Xu X; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
    Pilcer G; Vanderbist F; Amighi K
    J Pharm Sci; 2009 Apr; 98(4):1463-75. PubMed ID: 18752304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.